title: Clinical and economic outcome of a cardiopulmonary and metabolic rehabilitation program.
abstract: OBJECTIVE
  To evaluate the clinical and economic outcome of a Cardiopulmonary and Metabolic Rehabilitation Program (CPMR) created by an HMO.
  
  
  METHODS
  The sample was comprised of 96 clients, divided into two groups of 48 individuals (treatment group--TG, individuals who participated in the CPMR program, and control group--CG, individuals who did not participate in the program) of both genders, with age ranging between 54 and 79 years. Training time of the TG was 22 (+/-3) months. To assess the clinical outcome before and after CPMR, exercise tolerance, plasma lipoprotein profile (TC, LDL-C, HDL-C, TC/HDL-C and triglycerides), resting blood pressure (BP), and body composition (Body mass index--BMI and Waist-to-hip ratio--W/HR) were determined.
  
  
  RESULTS
  The TG presented the following results in the pre and post CPMR assessment, respectively: TC (mg/dL) 242.5 (+/-48,32) and 189.47(+/-39.83); LDL-C (mg/dL) 162(+/-37.72) and 116.3(+/-33.28); HDL-C (mg/dL) 46.5(+/-8.59) and 57.8(+/-10.36); Tg (mg/dL) 165.15(+/-90.24) and 113.29(+/-54.92); TC/HDL-C 5.42 (+/-1.10) and 3.35 (+/-0.81); VO2 peak (mL/Kg/min) 26.92 +/- 7 and 32.64 +/- 5.92; BMI 29.35 (+/-3.93) and 28.12 (+/-3.55) for women and 29.17 (+/-5.14) and 27.88 (+/-4.83) for men; W/HR 0.93(+/-0.05) and 0.94(+/-0.04) for women and 0.93(+/-0.07) and 0.92(+/-0.06) for men; BP (mmHg) 151(+/-13.89) and 132(+/-9.56); DBP (mmHg) 83(+/-8.07) and 77(+/-5.92); monthly expenses CG (R$) 8,840.05 (+/-5,656.58) and 8,978.32 (+/-5,500.78); monthly expenses TG (R$) 2,016.98 (+/-2,861.69) and 1,470.73 (+/-1,333.25).
  
  
  CONCLUSIONS
  In the group undergoing the CPMR Program, favorable clinical changes were observed in relation to the plasma lipoprotein profile, blood pressure, and exercise tolerance, with no relation to changes in medications.
authors.affiliation: Universidade do Estado de Santa Catarina, Florianópolis, SC, Brazil. fabirebelo@newsite.com.br
authors.forename: Fabiana Pereira Vecchio
authors.initials: FP
authors.lastname: Rebelo
authors.forename: Aline dos Santos
authors.initials: Ados S
authors.lastname: Garcia
authors.forename: Dalton Francisco de
authors.initials: DF
authors.lastname: Andrade
authors.forename: Cláudio Ribeiro
authors.initials: CR
authors.lastname: Werner
authors.forename: Tales de
authors.initials: Td
authors.lastname: Carvalho
mesh_terms: D000368:Aged; D001794:Blood Pressure / Q000502:physiology; D015992:Body Mass Index; D000072038:Cardiac Rehabilitation; D002318:Cardiovascular Diseases / Q000191:economics / Q000503:physiopathology; D003362:Cost-Benefit Analysis; D005081:Exercise Therapy / Q000191:economics*; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008171:Lung Diseases / Q000503:physiopathology / Q000534:rehabilitation*; D008297:Male; D008875:Middle Aged; D015397:Program Evaluation; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D049629:Waist-Hip Ratio
chemical_list: D008074:Lipoproteins